Helius Medical Technologies, Inc. (NASDAQ:HSDT) headquartered in Newtown, will host a conference call for the investment community to discuss the 3Q20 earnings result on 12th November 2020 at 5:45 PM Eastern Time.
Those interested in listening to the conference call live via the Internet can visit heliusmedical.com
Individuals interested in participating in the audio call may dial the listen only number(s) 877-407-2988 U.S. or 201-389-0923 Outside U.S., and the passcode is 13711025
Earnings Expectation
Helius Medical Technologies, Inc. is reporting third quarter financial results on Thursday 12th November 2020, after market close.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 2.00 million ~ $ 2.00 million
Click Here For More Historical Outlooks Of Helius Medical Technologies, Inc.
Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, or acquiring noninvasive technologies for the treatment of symptoms caused by neurological disease or trauma. The companys product is Portable Neuromodulation Stimulator, a medical device in Canada for the treatment of chronic balance deficit associated with a mild to moderate traumatic brain injury. Its PoNS device treats neurostimulation of cranial nerves via the tongue to restore lost function.
